226
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Anti-hyperuricemic property of 6-shogaol via self-micro emulsifying drug delivery system in model rats: formulation design, in vitro and in vivo evaluation

, , , , , , , , , , , & ORCID Icon show all
Pages 1265-1276 | Received 25 Dec 2018, Accepted 08 Mar 2019, Published online: 17 May 2019

References

  • Ye Y, Zhang Y, Wang B, et al. CXCR1/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy. Biomed Pharmacother. 2018;107:1142–1150.
  • Yang Q, Wang Q, Deng W, et al. Anti-hyperuricemic and anti-gouty arthritis activities of polysaccharide purified from Lonicera japonica in model rats. Int J Biol Macromol. 2019;123:801–809.
  • Wu Y, Wang Y, Ou J, et al. Effect and mechanism of ShiZhiFang on uric acid metabolism in hyperuricemic rats. Evid Based Complement Alternat Med. 2018;2018:1–11.
  • Silva CR, Fröhlich JK, Oliveira SM, et al. The antinociceptive and anti-inflammatory effects of the crude extract of Jatropha isabellei in a rat gout model. J Ethnopharmacol. 2013;145:205–213.
  • Tan BS, Kang O, Mai CW, et al. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). Cancer Lett. 2013;336:127–139.
  • Ghayur MN, Gilani AH, Afridi MB, et al. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul Pharmacol. 2005;43:234–241.
  • Etoh H, Kondoh T, Noda R, et al. Shogaols from Zingiber officinale as promising antifouling agents. Biosci Biotech Biochem. 2002;66:1748–1750.
  • Kim MO, Lee MH, Oi N, et al. [6]-Shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis. 2014;35:683–691.
  • Alqasoumi S, Yusufoglu H, Farraj A, et al. Effect of 6-shogaol and 6-gingerol on diclofenac sodium induced liver injury. Int J Pharmacol. 2011;7:868–873.
  • Hsu HF, Hsiao PC, Kuo TC, et al. Antioxidant and anti-inflammatory activities of Lonicera japonica Thunb. var. sempervillosa Hayata flower bud extracts prepared by water, ethanol and supercritical fluid extraction techniques. Ind Crop Prod. 2016;89:543–549.
  • Sabina EP, Rasool MK, Mathew L, et al. 6-Shogaol inhibits monosodium urate crystal-induced inflammation – An in vivo and in vitro study. Food Chem Toxicol. 2010;48:229–235.
  • Wang Q, Yang Q, Cao X, et al. Enhanced oral bioavailability and anti-gout activity of [6]-shogaol-loaded solid lipid nanoparticles. Int J Pharm. 2018;550:24–34.
  • Zick SM, Djuric Z, Ruffin MT, et al. Pharmacokinetics of 6-, 8-, 10-gingerols and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarker Prev. 2008;17:1930–1936.
  • Wang Y, Wang S, Firempong CK, et al. Enhanced solubility and bioavailability of Naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations. AAPS PharmSciTech. 2016;18:1–9.
  • Zhu Y, Wang M, Zhang J, et al. Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats. Arch Pharm Res. 2015;38:512–521.
  • Zhu Y, Peng W, Zhang J, et al. Enhanced oral bioavailability of capsaicin in mixed polymeric micelles: preparation, in vitro and in vivo evaluation. J Funct Foods. 2014;8:358–366.
  • Wang H, Li Q, Deng W, et al. Self-nanoemulsifying drug delivery system of trans-cinnamic acid: formulation development and pharmacodynamic evaluation in alloxan-induced type 2 diabetic rat model. Drug Dev Res. 2015;76:82–93.
  • Shi F, Zhao Y, Firempong CK, et al. Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers. Pharm Biol. 2016;54:2320–2328.
  • Cao M, Xue X, Pei X, et al. Formulation Optimization and pharmacokinetics evaluation of oral self-microemulsifying drug delivery system for poorly water soluble drug cinacalcet and no food effect. Drug Dev Ind Pharm. 2018;6:969–981.
  • Duc HN, Mitrevej A, Sathirakul K, et al. Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement. Drug Dev Ind Pharm. 2015;41:207–217.
  • Jovana J, Ljiljana D, Vladimir DI, et al. Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir. Int J Pharm. 2016;497:301–311.
  • Jiang D, Zeng J, Zhu Y, et al. Sustained-release of Cyclosporin A pellets: preparation, in vitro release, pharmacokinetic studies and in vitro-in vivo correlation in beagle dogs. Drug Dev Ind Pharm. 2016;42:1174–1182.
  • Bachhav YG, Patravale VB. SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies. AAPS PharmSciTech. 2009;10:482–487.
  • Sermkaew N, Ketjinda W, Boonme P, et al. Liquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from a crude extract of Andrographis paniculata. Eur J Pharm Sci. 2013;50:459–466.
  • Khataee AR, Fathinia M, Aber S, et al. Optimization of photocatalytic treatment of dye solution on supported TiO 2 nanoparticles by central composite design: intermediates identification. J Hazard Mater. 2010;181:886–897.
  • Xu Y, Wang Q, Feng Y, et al. Enhanced oral bioavailability of [6]-Gingerol-SMEDDS: Preparation, in vitro and in vivo evaluation. J Funct Foods. 2016;27:703–710.
  • Zhu J, Wang Q, Li H, et al. Galangin-loaded, liver targeting liposomes: optimization and hepatoprotective efficacy. J Drug Deliv Sci Technol. 2018;46:339–347.
  • Feng Y, Sun C, Omari-Siaw E, et al. An efficient in vitro and in vivo HPLC method for hydnocarpin in nanomicelles formulation. Biomed Chromatogr. 2016;30:432–439.
  • Swapna SR, Kadimi US. Characterization of gingerol analogues in supercritical carbon dioxide (SC CO2) extract of ginger (Zingiber officinale, R.,). J Food Sci Technol. 2014;51:3383–3389.
  • Varma MV, Khandavilli S, Ashokraj Y, et al. Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. Cdm. 2004;5:375–388.
  • Mu H, Holm R, Müllertz A. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm. 2013;453:215–224.
  • Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561.
  • Omari-Siaw E, Yuan Z, Wang H, et al. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: formulation, in vitro and in vivo evaluation. Eur J Pharm Sci. 2016;85:112–133.
  • Hu X, Chen L, Chen D, et al. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm. 2012;438:123–133.
  • Taniguchi K, Itakura K, Morisaki K, et al. Effects of Tween 80 and liposomes on the corneal permeability of anti-inflammatory steroids. J Pharmacobio-Dyn. 1988;11:685.
  • Chen L, Liu CS, Chen QZ, et al. Characterization, pharmacokinetics and tissue distribution of chlorogenic acid-loaded self-microemulsifying drug delivery system. Eur J Pharm Sci. 2017;100:102–108.
  • Kwak JS. Application of Taguchi and response surface methodologies for geometric error in surface grinding process. Int J Machine Tool Manufacture. 2005;45:327–334.
  • Omari-Siaw E, Wang Q, Sun C, et al. Tissue distribution and enhanced in vivo anti-hyperlipidemic-antioxidant effects of perillaldehyde-loaded liposomal nanoformulation against Poloxamer 407-induced hyperlipidemia. Int J Pharm. 2016;513:68–77.
  • Khoo SM, Humberstone AJ, Porter CJH, et al. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167:155–164.
  • Wang Q, Wei Q, Yang Q, et al. A novel formulation of [6]-gingerol: proliposomes with enhanced oral bioavailability and antitumor effect. Int J Pharm 2018;535:308–315.
  • Feng Y, Sun C, Yuan Y, et al. Enhanced oral bioavailability and in vivo antioxidant activity of chlorogenic acid via liposomal formulation. Int J Pharm. 2016;501:342–349.
  • Bhattarai S, Tran VH, Duke CC. Stability of [6]-gingerol and [6]-shogaol in simulated gastric and intestinal fluids. J Pharm Biomed Anal. 2007;45:648.
  • Dolman MEM, Harmsen S, Storm G, et al. Drug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cells. Adv Drug Deliv Rev. 2010;62:1344–1357.
  • Moon M, Kim HG, Choi JG, et al. 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia. Biochem Biophys Res Commun. 2014;449:8–13.
  • Lin S, Zhang G, Pan J, et al. Deciphering the inhibitory mechanism of genistein on xanthine oxidase in vitro. J Photochemi Photobiol B Biol. 2015;153:463–472.
  • Ferrari FC, De C, Ferraz Filha ZS, et al. Effects of Pimenta pseudocaryophyllus extracts on gout: anti-inflammatory activity and anti-hyperuricemic effect through xantine oxidase and uricosuric action. J Ethnopharmacol. 2016;180:37–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.